StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
AGM/EGMJun 3, 2026, 04:13 PM

DBV Technologies Shareholders Approve 2025 Financials, Amend Bylaws

AI Summary

DBV Technologies S.A. held its Annual Combined Meeting of Shareholders on June 3, 2026, where shareholders approved all thirty-nine proposals. Key approvals included the company's annual and consolidated financial statements for the year ended December 31, 2025, the renewal of KPMG as statutory auditor, and the ratification and renewal of several directors. Additionally, the company's bylaws were amended to set an age limit of 70 for the Chief Executive Officer and to comply with new French law provisions.

Key Highlights

  • Shareholders approved 2025 annual financial statements with 190,121,468 votes For.
  • Shareholders approved 2025 consolidated financial statements with 190,120,075 votes For.
  • KPMG's term as statutory auditor was renewed with 190,030,444 votes For.
  • Ms. Philina Lee's provisional appointment as director was ratified with 189,933,070 votes For.
  • Mr. Michael J. Goller's term as director was renewed with 184,088,474 votes For.
  • Mr. Daniel Tassé's term as director was renewed with 189,963,580 votes For.
  • Company bylaws were amended to set the Chief Executive Officer age limit at 70 years.
  • Bylaws were updated to comply with French law regarding the Ordinary Share Record Date.